A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: preliminary safety and immunogenicity

Liao, John

74 - Focused Plenary
A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: preliminary safety and immunogenicity

Sunday, March 23, 2014: 2:35 PM

Ballroom D (Tampa Convention Center)

J. B. Liao, D. L. Cecil, J. Reichow, S. Parker, D. Higgins, J. Childs, E. Broussard, A. Coveler, L. Salazar and M. L. Disis
University of Washington, Seattle, WA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

74 - Focused Plenary
A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: preliminary safety and immunogenicity

74 - Focused Plenary A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: preliminary safety and immunogenicity

74 - Focused Plenary
A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: preliminary safety and immunogenicity